Aurora Cannabis vs Organigram Global
ACB and OGI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACB and OGI compare
Organigram Global grew revenue faster over the last twelve months (77.8% versus 11.0% for Aurora Cannabis).
Aurora Cannabis scores higher on the StockData Score (6 against 4 for Organigram Global), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACB | OGI |
|---|---|---|
| Size and price | ||
| Share price | $4.94 | $0.829 |
| Change, 1 year | 9.1% | −48.5% |
| Change, 5 years | −93.0% | −89.6% |
| Beta (5Y) | 1.31 | 1.51 |
| StockData Score | ||
| Total score | 6 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 11.0% | 77.8% (better) |
| Revenue growth, 5Y average | 5.5% | 83.6% (better) |
| EPS growth (TTM) | −5450% | – |
| Profitability | ||
| Gross margin | 42.6% (better) | 34.8% |
| Operating margin | – | −5.9% |
| FCF margin | – | −9.5% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | −31.24 |
| Current ratio | 5.94 (better) | 2.26 |
| Ownership | ||
| Held by institutions | 8.9% | 5.7% |
| Held by insiders | 0.00% | 31.4% |
Go deeper
- ACB stock overview
- ACB income statement
- ACB valuation and score
- OGI stock overview
- OGI income statement
- OGI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.